Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chor S Chim

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|July 25, 2017
Lactate dehydrogenase as a prognostic marker in AL amyloidosis: expected or unexpected?Chor S Chim
Clinical Lymphoma & Myeloma|December 10, 2008
Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approachChor S Chim, Yok L Kwong, Raymond Liang
British Journal of Haematology|August 6, 2003
Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significanceChor S Chim, Seung Y Wong, Yok L Kwong
The American Journal of Medicine|April 18, 2002
Primary mucosa-associated lymphoid tissue lymphoma of the gallbladderChor S Chim, Raymond Liang, Florence Loong, et al.
The Journal of Molecular Diagnostics : JMD|March 11, 2020
Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple MyelomaQiumei Yao, Yinlei Bai, Alberto Orfao, et al.
Diagnostic Pathology|July 9, 2011
Atypical Burkitt's lymphoma transforming from follicular lymphomaYu Y Hwang, Florence Loong, Lap P Chung, et al.
The American Journal of Medicine|January 29, 2002
Primary skeletal muscle lymphomaChor S Chim, Florence Loong, Gaik C Ooi, et al.
British Journal of Haematology|February 21, 2020
Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostificationLu Q Wang, Shaji Kumar, George A Calin, et al.
British Journal of Haematology|May 15, 2004
FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impactWing Y Au, Alvin Fung, Chor S Chim, et al.
British Journal of Haematology|March 11, 2004
Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patientsShing Y Ma, Wing Y Au, Chor S Chim, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|July 25, 2017
Lactate dehydrogenase as a prognostic marker in AL amyloidosis: expected or unexpected?Chor S Chim
Clinical Lymphoma & Myeloma|December 10, 2008
Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approachChor S Chim, Yok L Kwong, Raymond Liang
British Journal of Haematology|August 6, 2003
Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significanceChor S Chim, Seung Y Wong, Yok L Kwong
The American Journal of Medicine|April 18, 2002
Primary mucosa-associated lymphoid tissue lymphoma of the gallbladderChor S Chim, Raymond Liang, Florence Loong, et al.
The Journal of Molecular Diagnostics : JMD|March 11, 2020
Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple MyelomaQiumei Yao, Yinlei Bai, Alberto Orfao, et al.
Diagnostic Pathology|July 9, 2011
Atypical Burkitt's lymphoma transforming from follicular lymphomaYu Y Hwang, Florence Loong, Lap P Chung, et al.
The American Journal of Medicine|January 29, 2002
Primary skeletal muscle lymphomaChor S Chim, Florence Loong, Gaik C Ooi, et al.
British Journal of Haematology|February 21, 2020
Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostificationLu Q Wang, Shaji Kumar, George A Calin, et al.
British Journal of Haematology|May 15, 2004
FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impactWing Y Au, Alvin Fung, Chor S Chim, et al.
British Journal of Haematology|March 11, 2004
Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patientsShing Y Ma, Wing Y Au, Chor S Chim, et al.
Pageof 2